Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
i would expect before may 15th
great news looks very promising here for HGEN
very nice report
agree 100% with you
toxic money kills 100% of the time
note holders own this company
.0001?
give it time, it will go lower
much tighter float here than 6 months ago
could increase 25% here
YES, COULD HIT $3 AND THEN $4 REAL QUICK
GREAT TRADE!
COULD BE A BIG WINNER HERE
CHART NOT GOOD HERE
NOT EXPECTING MUCH HERE IN NEXT 6 MONTHS
COULD BE A 10% GAIN COMING
SD should breakout today
expect sell-off today
great to see!
falling knife, social distance this one
i agree that TSLA is way over priced
up over 15% today
up 12.97% today
up 15.9 % today
great stock here
up 15.9 % today
great stock here
down over 4.5% today
up a good 10% today
up 2.5% today
down almost 4% today
up another 13%
.0001 soon?
yes as predicted lower SP, i doubt any news helps here
dog with fleas
all positive here with HWKE
good decision i am sure
yes i do believe higher
when is nevada opening up casinos?
more research needed here
recent news look promising for MESO
MESOBLAST PARTNERS WITH THE CARDIOTHORACIC SURGICAL TRIALS NETWORK ESTABLISHED BY THE U.S. NATIONAL INSTITUTES OF HEALTH’S NATIONAL HEART, LUNG AND BLOOD INSTITUTE TO CONDUCT RANDOMIZED CONTROLLED TRIAL OF REMESTEMCEL-L FOR PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME DUE TO COVID-19
could be more upside yet
MNOV appears to have great doctors working with MediciNova regarding clinical trial for COVID-19 Acute Respiratory Distress Syndrome (ARDS)
TLSA looks interesting
Tiziana Lifesciences Develops Novel Investigational Treatment For Patients Infected with COVID-19 Utilizing Direct Delivery of Anti-Interlukin-6-Receptor Monoclonal Antibodies